phenotypes may provide clues regarding the pathogenesis and prevention of subsequent asthma. The odds ratio (OR) of a diagnosis of MMA where sIgE to alpha-gal is positive is only 2.5 (95% CI 0.7-8.6, P = 0.16). The OR of the presence of atopy is 1.3 (95% CI 0.5-3.3, P = 0.64). However, the OR for a history of tick bite is 15.4 (95% CI 5.3-45.3, P < 0.001).
Methods:
We performed a retrospective analysis of results of sIgE to alpha-gal obtained between January 2014 and December 2016 inclusive in a tick-endemic population in Sydney, Australia. 118 results were included in the study.
Results:
We used a cut-off for positivity of 0.35 kUA/L. Fifty-nine results (49.6%) were positive, however, only 26 (21.8%) had MMA. Fifty-one subjects reported a history of tick bite from Ixodes holocyclus, and 31 (60.8%) had a positive test despite no clinical features of MMA.
The odds ratio (OR) of a diagnosis of MMA where sIgE to alpha-gal is positive is only 2.5 (95% CI 0.7-8.6, P = 0.16). The OR of the presence of atopy is 1.3 (95% CI 0.5-3.3, P = 0.64). However, the OR for a history of tick bite is 15.4 (95% CI 5.3-45.3, P < 0.001).
Conclusions: sIgE to alpha-gal does not add any further information to clinical history in the diagnosis of MMA. It only confirms that the patient has had a tick bite (in our population by Ixodes holocyclus). In our experience, this can be ascertained by the individual or at a clinical review. A reduction in the number of assays to sIgE to alpha-gal performed would reduce costs to these tick-endemic communities. Objectives: The purpose of the study was to describe the food allergy profile and determine feeding disorder and faltering growth rates in 0-24 month old food allergic children newly presenting to a tertiary Allergy clinic in Southern Adelaide.
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Methodology: A 12-month single centre retrospective case note review was conducted for all children aged 0-24 months, attending their initial Allergy clinic appointment from 1 July 2011 to 30 June 2012. Data was collected on food allergy clinical characteristics as well as anthropometric data for birth, initial appointment and 24 months of age to determine growth trajectory. A fall through 2 or more World Health Organisation percentile lines from birth for one or more anthropometric measures defined faltering growth for our cohort.
Results: Food allergies included egg, peanut, cow's milk protein, present in 62 (67%), 47 (51%) and 45 (49%) respectively. Allergies were exclusively IgE mediated in 54 (59%) and purely non-IgE mediated in 14 (15%); 24 (26%) had concurrent IgE and non-IgE mediated food allergies. 81 (90%) experienced chronic food allergy and atopy related symptoms. Feeding disorders were identified in 20 (22%). Faltering growth was evident in 25 (27%) at initial appointment, which resolved following clinical intervention in 10 (77%) of 13 children measured at 24 months of age.
Conclusions: Chronic food allergy and atopy associated symptoms were almost universal, indicating substantial disease burden. Feeding disorders and faltering growth were both common and we recommend all infants with food allergy to be regarded as vulnerable and receive proactive assessment and intervention for these complications of food allergy. In 2011, the Health Nuts study revealed '10.5% of Melbourne Children have challenge proven food allergy' (Allen, K. JACI 2011)
Aim: The aim was to perform an up to date audit of challenge provision in the setting of a highly food allergy susceptible population.
Method: A retrospective data base review of all paediatric challenges was performed over a 12 month period from May 2016 to April 2017.
The purpose of this audit was to determine:
• Of these, 86% were food challenges, 9% were drug challenges and 5% other (latex, exercise, vaccine and intradermal testing) with a rate of positive challenges of 16%, anaphylaxis of 1% of all challenges and 8% of all positive oral food challenges. The median age of patients was 7.9 years.
Conclusion:
This data enables us to continue to develop allergy services to satisfy current demand and to plan for future needs in this evolving allergy population. Paediatric food allergy practice requires access to an observed food challenge (OFC), the gold standard investigative tool. This process requires supervision by trained health professionals experienced in management of acute allergic reactions, including anaphylaxis. In New Zealand, OFCs are done in both a tertiary care paediatric center (Starship Children's Hospital -SCH) as well as numerous regional paediatric sites. We present the prospective data obtained from food challenges undertaken in an 18-month period from September 2015 to March 2017.
P47 PAEDIATRIC OBSERVED FOOD CHALLENGES IN NEW ZEALAND: A CASE FOR DIVERSIFYING CARE
Methods: Food challenges were conducted at 6 regional paediatric centers across the North and South Island and at SCH, Auckland. Decision for OFC was made by the treating physician and based on history and testing for food specific IgE (skin prick and/or serum specific IgE). Open label food challenge protocols were standardised to the ASCIA guidelines where possible and published 'stop' criteria were employed. Data was prospectively obtained, deidentified, compiled and analysed at the end of the study period. 
